Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | HSD17B2 |
| Upstream (Parents) |
|---|
| (<<) CYP4A22 → HSD17B2 |
| (<<) APOM → HSD17B2 |
| (<<) SALL1 → HSD17B2 |
| Downstream (Children) |
|---|
| HSD17B2 → ITPKA (>>) |
| HSD17B2 → DENND5B (>>) |
| HSD17B2 → RAP2A (>>) |
| HSD17B2 → TTLL4 (>>) |
| HSD17B2 → VTCN1 (>>) |
| HSD17B2 → LRAT (>>) |
| HSD17B2 → BAI2 (>>) |
